MRNA EBITDA
Moderna · EBITDA
MRNA EBITDA
Latest reported-$2.83Bperiod ending
MRNA TTM EBITDA (-$248.82M → -$2.83B)
TTM EBITDA
High-resolution chart · PNG
MRNA ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -2,829,000,000 | |
| -2,885,000,000 | |
| -2,551,000,000 | |
| -2,937,000,000 | |
| -2,723,000,000 | |
| -3,195,000,000 | |
| -3,394,000,000 | |
| -1,998,000,000 | |
| -3,776,000,000 | |
| -4,188,000,000 | |
| -3,283,000,000 | |
| -1,816,000,000 | |
| 1,221,000,000 | |
| 5,420,000,000 | |
| 9,944,000,000 | |
| 13,687,000,000 | |
| 15,975,000,000 | |
| 16,557,000,000 | |
| 13,529,000,000 | |
| 7,781,202,000 | |
| 3,933,764,000 | |
| 690,077,000 | |
| -702,972,000 | |
| -556,649,000 | |
| -449,740,000 | |
| -469,390,000 | |
| -478,161,000 | |
| -497,069,000 | |
| -456,390,000 | |
| -414,645,000 | |
| -358,021,000 | |
| -261,551,000 | |
| -250,441,000 | |
| -240,932,000 | |
| -248,819,000 |